YASO THERAPEUTICS INCORPORATED
Scottsdale, AZ · Biotech · Private
PPCM-GEL, a non-hormonal vaginal contraceptive gel with spermicidal and antimicrobial properties
yasotherapeutics.com →- Grants
- $7.1M
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Preclinical development of PPCM vaginal contraceptive to submit IND. | $1,967,467 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Preclinical development of PPCM vaginal contraceptive to submit IND. | $985,250 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical development of PPCM vaginal contraceptive to submit IND. | $982,217 | |
| Federal grant | Department of Health and Human Services · Phase II · Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | $999,102 | |
| Federal grant | Department of Health and Human Services · Phase II · Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | $984,778 | |
| Federal grant | Department of Health and Human Services · Phase I · Preparation and submission of an IND for PPCM Gel contraceptive | $298,521 | |
| Federal grant | Department of Health and Human Services · Phase I · Preparation and submission of an IND for PPCM Gel contraceptive | $298,521 | |
| Federal grant | Department of Health and Human Services · Phase II · First in Human Clinical Trial of a Contraceptive MPT YASO GEL | $545,966 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1375 | LAUREN SCIENCES, LLC | — | — |
| 1376 | HELIXOMER, INC. | — | — |
| 1377 | Vcreate, Inc. | — | — |
| 1378 | YASO THERAPEUTICS INCORPORATED | — | — |
| 1379 | CHIMERNA THERAPEUTICS, INC. | — | — |
| 1380 | Monopar Therapeutics | — | $2.1M |
| 1381 | INFLAMED, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.